Health Disparities in Utilization, Quality, and Outcomes for Three Common Ocular Conditions (HealthDOC)

三种常见眼部疾病的利用、质量和结果方面的健康差异 (HealthDOC)

基本信息

  • 批准号:
    10559239
  • 负责人:
  • 金额:
    $ 46.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-03-01 至 2028-02-29
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract: Multiple that minority CHIP of The understood. ophthalmology retinopathy. past studies provide strong evidence that disparities exist in healthcare, i ncluding in ophthalmology, and social determinant of health (SDH) play an important role for explaining differences in ethnic and racial receipt of healthcare. With the passage of the Affordable Care Act and later the Medicare Access and Reauthorization Act of 2015, there has been emphasis on medical quality measures with implementation the Medicare Incentive Payment System (MIPS) with the use of National Quality Forum (NQF) related metrics. association between quality measures for ophthalmic conditions and healthcare disparities is poorly In fact, there has been little research to inform how the social determinants of health impact care practices and quality metrics by racial/ethnic groups with cataract, glaucoma, and diabetic The proposedHealth Disparities in Utilization, Quality, and Outcomes for Three Common Ocular Conditions (HealthDOC) study employing clinically will address prevailing gaps between clinical quality measures and practice by a rigorous health services and outcomes research study design that evaluates ophthalmic NQF, and meaningful measures using the S ight OU tcomes R esearch C ollaborativ E ( SOURCE to study health) disparities. SOURCE links and extracts data across healthcare systems from electronic health records to capture visual changes, clinical details (typically not available but through clinical trials), and health disparities, which is ideal for responding to Healthy People 2030 ocular goals. SOURCE overcomes major data barriers in ophthalmology health disparities work with visual outcome details for measuring treatment, quality, and outcomes, joined with key information on race and ethnicity, the biological variable of gender, SDH measures, medications, hemoglobin A1c, Centers for Disease Control National Death Index Data and others. This study will examine three major eye diseases (cataract, glaucoma, diabetic eye disease) and quantify the impact of SDH on achievement of established and peer reviewed NQF ocular quality metrics, and clinically meaningful measures on visual outcomes, and non-ocular morbidity and mortality for the chronic diseases of glaucoma and diabetic retinopathy. The ocular conditions we focus on are the most common causes of irreversible visual impairment and blindness in the U.S. and fulfills the target goals for National Eye Institute and Healthy People 2030. This on Eye Care Disparities), leveraging states disparities National innovative, 2 stakeholder-driven 3 ) aligned with healthcare management using accepted quality metrics (NQF), and 4 existing data from electronic health records of 27 ophthalmology program sites covering multiple and regions, focused on quality improvement initiatives aimed at future interventions to reduce health across SOURCE sites and abroad. This project aligns well with the missions of the NIH, NEI, and Academy of Medicine (NAM) on reducing health disparities and the prevention of vision loss. study is: 1) ) (American Academy of Ophthalmology, Task Force )
项目概要/摘要: 多 的 少数 芯片 的 的 明白 眼科 视网膜病变 过去的研究提供了强有力的证据表明,在医疗保健方面存在差异,包括眼科, 健康社会决定因素(SDH)在解释民族和种族 接受医疗保健。随着《平价医疗法案》和后来的《医疗保险准入法案》的通过, 2015年的再授权法案,强调了医疗质量措施的实施 医疗保险激励支付系统(MIPS),使用国家质量论坛(NQF)相关指标。 眼科疾病的质量指标与医疗保健差异之间的相关性很差 事实上,很少有研究表明健康的社会决定因素如何影响 白内障、青光眼和糖尿病患者种族/族裔群体的护理实践和质量指标 三种常见眼科手术在利用、质量和结果方面的拟议健康差异 条件(HealthDOC)研究 采用 临床 将解决临床质量措施和实践之间的普遍差距, 严格的卫生服务和结果研究设计,评估眼科NQF,以及 使用健康研究资源的有意义的措施 差距。SOURCE从电子健康记录中链接并提取医疗保健系统中的数据, 视觉变化,临床细节(通常无法获得,但通过临床试验)和健康差异, 是响应2030年健康人眼科目标的理想选择。SOURCE克服了主要的数据障碍, 眼科健康差异与视觉结果细节一起工作,用于测量治疗、质量和 结果,加上种族和民族的关键信息,性别的生物变量,SDH措施, 药物,血红蛋白A1 c,疾病控制中心国家死亡指数数据和其他。本研究 将检查三种主要的眼科疾病(白内障,青光眼,糖尿病眼病),并量化 SDH对实现既定和同行评审的NQF眼部质量指标的影响,并具有临床意义 测量青光眼慢性疾病的视力结局和非眼部发病率和死亡率, 糖尿病视网膜病变我们关注的眼部疾病是不可逆视觉障碍的最常见原因。 在美国的损害和失明,并实现了国家眼科研究所和健康人的目标 2030.这 关于眼部护理差异), 利用 国 差距 国家 创新,2个利益相关者驱动 3)使用公认的质量指标(NQF)与医疗保健管理保持一致,以及4 现有数据来自27个眼科项目点的电子健康记录, 和区域,重点是质量改进举措,旨在未来采取干预措施, 在国外和国外的来源网站。该项目与NIH、NEI和 医学科学院(NAM)关于减少健康差距和预防视力丧失。 研究是:1))(美国眼科学会,工作组 )

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DUSTIN D. FRENCH其他文献

DUSTIN D. FRENCH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DUSTIN D. FRENCH', 18)}}的其他基金

Understanding Diabetic Eye Disease in the Underserved Using Health Data Exchange
使用健康数据交换了解服务不足的地区的糖尿病眼病
  • 批准号:
    8769287
  • 财政年份:
    2014
  • 资助金额:
    $ 46.43万
  • 项目类别:
Understanding Diabetic Eye Disease in the Underserved Using Health Data Exchange
使用健康数据交换了解服务不足的地区的糖尿病眼病
  • 批准号:
    8928622
  • 财政年份:
    2014
  • 资助金额:
    $ 46.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了